A Comparative Analysis of D-Dimer Assays in Patients with Clinically Suspected Pulmonary Embolism

Summary To avoid angiography in patients with clinically suspected pulmonary embolism and non-diagnostic lung scan results, the use of D-dimer has been advocated. We assessed plasma samples of 151 consecutive patients with clinically suspected pulmonary embolism. Lung scan results were: normal (43), high probability (48) and non-diagnostic (60; angiography performed in 43; 12 pulmonary emboli). Reproducibility, cut-off values, specificity, and percentage of patients in whom angiography could be avoided (with sensitivity 100%) were determined for two latex and four ELISA assays. The latex methods (cut-off 500 μg/1) agreed with corresponding ELISA tests in 83% (15% normal latex, abnormal ELISA) and 81% (7% normal latex, abnormal ELISA). ELISA methods showed considerable within- (2–17%) and between-assay Variation (12–26%). Cut-off values were 25 μg/l (Behring), 50 μg/l (Agen), 300 μg/l (Stago) and 550 μg/l (Organon). Specificity was 14–38%; in 4–15% of patients angiography could be avoided. We conclude that latex D-dimer assays appear not useful, whereas ELISA methods may be of limited value in the exclusion of pulmonary embolism.

[1]  H. Büller,et al.  The Use of the D-Dimer Test in Combination with Non-Invasive Testing Versus Serial Non-Invasive Testing Alone for the Diagnosis of Deep-Vein Thrombosis , 1992, Thrombosis and Haemostasis.

[2]  P. Brill-Edwards,et al.  D-Dimer and Thrombin-Antithrombin III Complexes in Patients with Clinically Suspected Pulmonary Embolism , 1992, Thrombosis and Haemostasis.

[3]  D. Slosman,et al.  Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism , 1991, The Lancet.

[4]  B. Boneu,et al.  D-Dimers, Thrombin Antithrombin III Complexes and Prothrombin Fragments 1 + 2: Diagnostic value in Clinically Suspected Deep Vein Thrombosis , 1991, Thrombosis and Haemostasis.

[5]  G. Raskob,et al.  Low-probability lung scan findings: a need for change. , 1991, Annals of internal medicine.

[6]  J. Mckillop,et al.  Lung scanning for pulmonary embolism: clinical and pulmonary angiographic correlations. , 1990, The Quarterly journal of medicine.

[7]  E. Minar,et al.  D-Dimer and TAT Measurement in Patients with Deep Venous Thrombosis: Utility in Diagnosis and Judgement of Anticoagulant Treatment Effectiveness , 1990, Thrombosis and Haemostasis.

[8]  A. Whitaker,et al.  Plasma cross linked fibrin degradation products in pulmonary embolism. , 1990, Thorax.

[9]  P. Investigators,et al.  Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). , 1990, JAMA.

[10]  D. Rylatt,et al.  A latex agglutination assay for D dimer: evaluation and application to the diagnosis of thrombotic disease. , 1987, Clinical chemistry.

[11]  C. Francis,et al.  Physiologic regulation and pathologic disorders of fibrinolysis. , 1987, Human pathology.

[12]  D. Rylatt,et al.  Measurement of Crosslinked Fibrin Derivatives -Use in the Diagnosis of Venous Thrombosis , 1987, Thrombosis and Haemostasis.

[13]  J. Menzoian,et al.  Can ventilation-perfusion scans accurately diagnose acute pulmonary embolism? , 1986, Archives of surgery.

[14]  D. Rylatt,et al.  Measurement of Crosslinked Fibrin Degradation Products – An Immunoassay Using Monoclonal Antibodies , 1983, Thrombosis and Haemostasis.

[15]  J. Wilson,et al.  Diagnostic value of tests of fibrin metabolism in patients predisposed to pulmonary embolism. , 1979, Archives of internal medicine.

[16]  J. Hirsh,et al.  Plasma fibrinopeptide A levels in symptomatic venous thromboembolism. , 1978, Blood.

[17]  E D Robin,et al.  Overdiagnosis and overtreatment of pulmonary embolism: the emperor may have no clothes. , 1977, Annals of internal medicine.

[18]  P. Gaffney,et al.  Distinction between fibrinogen and fibrin degradation products in plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[19]  T. Chard,et al.  SERUM FIBRIN(OGEN) DEGRADATION PRODUCTS IN DIAGNOSIS OF DEEP-VEIN THROMBOSIS AND PULMONARY EMBOLISM AFTER HIP SURGERY , 1975, The Lancet.

[20]  J. M. Black,et al.  The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle , 1972, Journal of clinical pathology.

[21]  R. B. Hunter,et al.  ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM , 1960 .

[22]  G. Raskob,et al.  Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. , 1990, Chest.

[23]  P. de Moerloose,et al.  Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. , 1989, American Journal of Clinical Pathology.

[24]  W. McCartney,et al.  The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. , 1981, The American journal of medicine.